Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Implications of Differential Expression of β-Catenin in Oral Carcinoma.

Moles MA, Montoya JA, Salvago MD, Ávila IR, Campillo JJ, Bravo M.

Anticancer Res. 2016 Apr;36(4):1599-604.

PMID:
27069136
2.

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.

Rodon J, Tawbi HA, Thomas AL, Stoller RG, Turtschi CP, Baselga J, Sarantopoulos J, Mahalingam D, Shou Y, Moles MA, Yang L, Granvil C, Hurh E, Rose KL, Amakye DD, Dummer R, Mita AC.

Clin Cancer Res. 2014 Apr 1;20(7):1900-9. doi: 10.1158/1078-0432.CCR-13-1710. Epub 2014 Feb 12.

3.

Dedifferentiation occurring in adenoid cystic carcinoma of the tongue.

Moles MA, Avila IR, Archilla AR.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):177-80.

PMID:
10468462

Supplemental Content

Loading ...
Support Center